3-((1S,2S)-1-(5-((4S)-2,2-DIMETHYLOXAN-4-YL)-2-((4S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-3-(3-(4-FLUORO-2-METHYLINDAZOL-5-YL)-2-OXOIMIDAZOL-1-YL)-4-METHYL-6,7-DIHYDRO-4H-PYRAZOLO(4,3-C)PYRIDINE-5-CARBONYL)INDOL-1-YL)-2-METHYLCYCLOPROPYL)-4H-1,2,4-OXADIAZOL-5-ONE
UNII 3Y2HRQ49P3

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-((1s,2s)-1-(5-((4s)-2,2-dimethyloxan-4-yl)-2-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-3-(3-(4-fluoro-2-methylindazol-5-yl)-2-oxoimidazol-1-yl)-4-methyl-6,7-dihydro-4h-pyrazolo(4,3-c)pyridine-5-carbonyl)indol-1-yl)-2-methylcyclopropyl)-4h-1,2,4-oxadiazol-5-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3Y2HRQ49P3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3Y2HRQ49P3
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
3-((1S,2S)-1-(5-((4S)-2,2-DIMETHYLOXAN-4-YL)-2-((4S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-3-(3-(4-FLUORO-2-METHYLINDAZOL-5-YL)-2-OXOIMIDAZOL-1-YL)-4-METHYL-6,7-DIHYDRO-4H-PYRAZOLO(4,3-C)PYRIDINE-5-CARBONYL)INDOL-1-YL)-2-METHYLCYCLOPROPYL)-4H-1,2,4-OXADIAZOL-5-ONE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C48H48F2N10O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UWIQUGSKWZLIPV-KHIFEHGGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
176488793
Unique identification number in the NCBI database of chemical substances.
Substance Type
3-[(1S,2S)-1-[5-[(4S)-2,2-Dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-2-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
Fc1c(cc(-n2nc3CCN([C@H](c3c2-n4c(=O)n(-c5c(F)c6c(nn(c6)C)cc5)cc4)C)C(=O)c7n(c8ccc(cc8c7)[C@@H]9CC(OCC9)(C)C)[C@]%10(c%11noc([nH]%11)=O)[C@@H](C)C%10)cc1C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-((1s,2s)-1-(5-((4s)-2,2-dimethyloxan-4-yl)-2-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-3-(3-(4-fluoro-2-methylindazol-5-yl)-2-oxoimidazol-1-yl)-4-methyl-6,7-dihydro-4h-pyrazolo(4,3-c)pyridine-5-carbonyl)indol-1-yl)-2-methylcyclopropyl)-4h-1,2,4-oxadiazol-5-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Orforglipron Impurity 86

Systematic Nomenclature

3-[(1S,2S)-1-[5-[(4S)-2,2-Dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-2-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound